삼성서울병원

Ko En

Park, Hee Chul M.D

TITLE
Associate Professor of Department of Radiation Oncology, Samsung Medical Center
Treament Schedule 06 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 07 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical School

Yonsei University College of Medicine

Specialty Training

Fellowship   Yonsei Cancer Center
Chosun University Hospital
Residency   Yonsei Cancer Center
Internship   Severance Hospital

Other Education

MS: Yonsei University College of Medicine
Ph.D: Yonsei University College of Medicine
Visiting Instructor: Hokkaido University Hospital
Visiting Scientist: MD Anderson Cancer Center

Clinical & Research Interests

Liver Cancer
Lung Cancer

Participation in Academic Societies
and Research

Korean Society for Therapeutic Radiology and Oncology (KOSTRO)
European Society for Therapeutic Radiology and Oncology (ESTRO)
Korean Society of Medical Physics
Korean Society for Head and Neck Oncology
The Korean Liver Cancer Study Group
Korean Association for the Study of Lung Cancer

Selected Publications

  • J CLIN ONCOL 2019 10.1200/JCO.19.00016 Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial Hong1, YS; Kim, SY; Lee, JS; Nam, BH; Kim, KP; Kim, JE; Park, YS; Park, JO; Baek, JY; Kim, TY; Lee, KW; Ahn, JB; Lim, SB; Yu, CS; Kim, JC; Yun, SH; Kim, JH; Park, JH; Park, HC; Jung, KH; Kim, TW
    View PubMed
  • Cancer Med 2019 10.1002/cam4.2570 Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-50594-2 Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK
    View PubMed
  • J APPL CLIN MED PHYS 2019 10.1002/acm2.12718 Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator Lee1, B; Jeong, S; Chung, K; Yoon, M; Park, HC; Han, Y; Jung, SH
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.687 Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B Korea (KROG 16-05) Bae1, SH; Park, HC; Yoon, WS; Yoon, SM; Jung, IN; Lee, IJ; Kim, JW; Seong, J; Kim, TH; Nam, TK; Choi, Y; Lee, SY; Jang, HS; Lee, DS; Kim, JH
    View PubMed